IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,748,397 | +26.6% | 258,308 | +25.2% | 0.01% | +11.1% |
| Q1 2023 | $2,170,360 | +2.9% | 206,308 | +21.1% | 0.01% | -18.2% |
| Q4 2022 | $2,109,943 | +52.6% | 170,294 | +27.5% | 0.01% | +37.5% |
| Q3 2022 | $1,383,000 | -18.4% | 133,531 | -9.2% | 0.01% | -38.5% |
| Q2 2022 | $1,695,000 | +140.1% | 147,025 | +161.9% | 0.01% | +116.7% |
| Q1 2022 | $706,000 | -61.4% | 56,140 | -64.2% | 0.01% | -57.1% |
| Q4 2021 | $1,828,000 | +104.2% | 156,795 | +128.9% | 0.01% | +27.3% |
| Q3 2021 | $895,000 | +13.0% | 68,501 | -1.5% | 0.01% | 0.0% |
| Q4 2020 | $792,000 | +40.9% | 69,532 | +27.6% | 0.01% | +37.5% |
| Q2 2020 | $562,000 | +244.8% | 54,505 | +236.6% | 0.01% | +14.3% |
| Q1 2020 | $163,000 | 0.0% | 16,194 | +32.1% | 0.01% | +40.0% |
| Q4 2019 | $163,000 | – | 12,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
| Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
| SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
| BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
| Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
| Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
| Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
| Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
| Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |